UK markets close in 37 minutes
  • FTSE 100

    5,731.40
    -60.61 (-1.05%)
     
  • FTSE 250

    17,593.15
    -260.15 (-1.46%)
     
  • AIM

    971.97
    -4.41 (-0.45%)
     
  • GBP/EUR

    1.1048
    +0.0027 (+0.25%)
     
  • GBP/USD

    1.3073
    +0.0052 (+0.40%)
     
  • BTC-GBP

    10,352.20
    +279.82 (+2.78%)
     
  • CMC Crypto 200

    268.76
    +7.47 (+2.86%)
     
  • S&P 500

    3,400.07
    -0.90 (-0.03%)
     
  • DOW

    27,586.52
    -98.86 (-0.36%)
     
  • CRUDE OIL

    39.24
    +0.68 (+1.76%)
     
  • GOLD FUTURES

    1,912.30
    +6.60 (+0.35%)
     
  • NIKKEI 225

    23,485.80
    -8.54 (-0.04%)
     
  • HANG SENG

    24,787.19
    -131.59 (-0.53%)
     
  • DAX

    12,041.78
    -135.40 (-1.11%)
     
  • CAC 40

    4,728.07
    -88.05 (-1.83%)
     

Thyroid Eye Disease Treatments Market Research Report by Drug, by Route of Administration, by Treatment, by Diagnosis, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·6-min read

Thyroid Eye Disease Treatments Market Research Report by Drug (Corticosteroid, Monoclonal Antibody, and Vitamin), by Route of Administration (Oral and Topical), by Treatment, by Diagnosis, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Thyroid Eye Disease Treatments Market Research Report by Drug, by Route of Administration, by Treatment, by Diagnosis, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05942172/?utm_source=GNW

The Global Thyroid Eye Disease Treatments Market is expected to grow from USD 211.49 Million in 2019 to USD 344.18 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.45%.

Market Segmentation & Coverage:
This research report categorizes the Thyroid Eye Disease Treatments to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Monoclonal Antibody is projected to witness the highest growth during the forecast period"

Based on Drug, the Thyroid Eye Disease Treatments Market studied across Corticosteroid, Monoclonal Antibody, and Vitamin. The Vitamin commanded the largest size in the Thyroid Eye Disease Treatments Market in 2019. On the other hand, the Monoclonal Antibody is expected to grow at the fastest CAGR during the forecast period.

"The Topical is projected to witness the highest growth during the forecast period"

Based on Route of Administration, the Thyroid Eye Disease Treatments Market studied across Oral and Topical. The Oral commanded the largest size in the Thyroid Eye Disease Treatments Market in 2019. On the other hand, the Topical is expected to grow at the fastest CAGR during the forecast period.

"The Radioactive Iodine Therapy is projected to witness the highest growth during the forecast period"

Based on Treatment, the Thyroid Eye Disease Treatments Market studied across Medication, Radioactive Iodine Therapy, and Surgery. The Medication commanded the largest size in the Thyroid Eye Disease Treatments Market in 2019. On the other hand, the Radioactive Iodine Therapy is expected to grow at the fastest CAGR during the forecast period.

"The Radioactive Iodine Uptake Test is projected to witness the highest growth during the forecast period"

Based on Diagnosis, the Thyroid Eye Disease Treatments Market studied across Blood Test, Imaging Test, Physical Exam, Radioactive Iodine Uptake Test, and Orbital Ultrasound. The Blood Test commanded the largest size in the Thyroid Eye Disease Treatments Market in 2019. On the other hand, the Radioactive Iodine Uptake Test is expected to grow at the fastest CAGR during the forecast period.

"The Online Pharmacy is projected to witness the highest growth during the forecast period"

Based on Distribution, the Thyroid Eye Disease Treatments Market studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy. The Hospital Pharmacy commanded the largest size in the Thyroid Eye Disease Treatments Market in 2019. On the other hand, the Online Pharmacy is expected to grow at the fastest CAGR during the forecast period.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Thyroid Eye Disease Treatments Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Thyroid Eye Disease Treatments Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Thyroid Eye Disease Treatments Market including Abbott Laboratories, AbbVie, Inc, Allergan plc, Bausch & Lomb Inc, Eyevance Pharmaceuticals LLC, GlaxoSmithKline plc, Hi-Tech Pharmacal Co Inc, Horizon Therapeutics plc, Kala Pharmaceuticals Inc, Merck & Co., Inc, Mylan N.V., Novartis AG, Pfizer Inc, Pharmos Corp, and RLC LABS.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Thyroid Eye Disease Treatments Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Thyroid Eye Disease Treatments Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Thyroid Eye Disease Treatments Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Thyroid Eye Disease Treatments Market?
4. What is the competitive strategic window for opportunities in the Global Thyroid Eye Disease Treatments Market?
5. What are the technology trends and regulatory frameworks in the Global Thyroid Eye Disease Treatments Market?
6. What are the modes and strategic moves considered suitable for entering the Global Thyroid Eye Disease Treatments Market?
Read the full report: https://www.reportlinker.com/p05942172/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001